#710 — The Industry Wire

  1. HHS cancels funding for Moderna’s H5 avian flu vaccine.
  2. Common herbal supplements could be linked to liver damage.
  3. Omada Health begins IPO, wants $1.1B valuation.
  4. Hinge Health’s IPO reignites digital health optimism.
  5. How provider collaborations are cutting hospital readmissions.
  6. Healthcare leaders rethinking strategy amid market volatility.
  7. Express Scripts, CVS sue Arkansas over PBM pharmacy ownership ban.
  8. ‘Night float’ schedule boosts radiologist productivity.
  9. Can a nasal spray slow down Alzheimer’s?
  10. Best Buy restructures its health unit.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Imaging Wire team

You're all set!